News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
701,651 Results
Type
Article (66303)
Company Profile (175)
Press Release (635159)
Multimedia
Podcasts (110)
Webinars (25)
Section
Business (183267)
Career Advice (3021)
Deals (33916)
Drug Delivery (139)
Drug Development (79476)
Employer Resources (193)
FDA (15700)
Job Trends (14849)
News (320188)
Policy (30693)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2946)
Academic (2)
Accelerated approval (34)
Adcomms (30)
Allergies (143)
Alliances (46573)
ALS (173)
Alzheimer's disease (1668)
Antibody-drug conjugate (ADC) (312)
Approvals (15957)
Artificial intelligence (568)
Autoimmune disease (162)
Automation (41)
Bankruptcy (308)
Best Places to Work (11476)
BIOSECURE Act (20)
Biosimilars (187)
Biotechnology (106)
Bladder cancer (156)
Brain cancer (61)
Breast cancer (636)
Cancer (4793)
Cardiovascular disease (407)
Career advice (2570)
Career pathing (42)
CAR-T (296)
CDC (47)
Celiac Disease (2)
Cell therapy (783)
Cervical cancer (37)
Clinical research (67741)
Collaboration (1735)
Company closure (5)
Compensation (816)
Complete response letters (61)
COVID-19 (2794)
CRISPR (96)
C-suite (907)
Cystic fibrosis (149)
Data (6214)
Decentralized trials (2)
Denatured (44)
Depression (139)
Diabetes (483)
Diagnostics (6788)
Digital health (48)
Diversity (13)
Diversity, equity & inclusion (46)
Drug discovery (268)
Drug pricing (196)
Drug shortages (27)
Duchenne muscular dystrophy (221)
Earnings (67485)
Editorial (61)
Employer branding (25)
Employer resources (166)
Events (106822)
Executive appointments (1040)
FDA (18842)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (10)
Frontotemporal dementia (24)
Funding (1508)
Gene editing (206)
Generative AI (54)
Gene therapy (599)
GLP-1 (972)
Government (4900)
Grass and pollen (7)
Guidances (381)
Healthcare (18889)
HIV (56)
Huntington's disease (44)
IgA nephropathy (81)
Immunology and inflammation (239)
Immuno-oncology (55)
Indications (105)
Infectious disease (3060)
Inflammatory bowel disease (196)
Inflation Reduction Act (14)
Influenza (118)
Intellectual property (249)
Interviews (558)
IPO (15601)
IRA (48)
Job creations (3692)
Job search strategy (2123)
JPM (62)
Kidney cancer (17)
Labor market (88)
Layoffs (613)
Leadership (39)
Legal (6856)
Liver cancer (90)
Longevity (14)
Lung cancer (646)
Lymphoma (368)
Machine learning (44)
Management (63)
Manufacturing (781)
MASH (168)
Medical device (13369)
Medtech (13424)
Mergers & acquisitions (19433)
Metabolic disorders (1254)
Multiple sclerosis (156)
NASH (20)
Neurodegenerative disease (320)
Neuropsychiatric disorders (90)
Neuroscience (2900)
Neurotech (1)
NextGen: Class of 2026 (6653)
Non-profit (4548)
Now hiring (66)
Obesity (581)
Opinion (303)
Ovarian cancer (165)
Pain (207)
Pancreatic cancer (225)
Parkinson's disease (278)
Partnered (34)
Patents (505)
Patient recruitment (507)
Peanut (58)
People (62355)
Pharmaceutical (40)
Pharmacy benefit managers (26)
Phase 1 (21274)
Phase 2 (29800)
Phase 3 (21952)
Pipeline (5196)
Policy (285)
Postmarket research (2586)
Preclinical (9189)
Press Release (69)
Prostate cancer (244)
Psychedelics (48)
Radiopharmaceuticals (281)
Rare diseases (845)
Real estate (6284)
Recruiting (79)
Regulatory (23370)
Reports (60)
Research institute (2587)
Resumes & cover letters (482)
Rett syndrome (28)
RNA editing (17)
RSV (73)
Schizophrenia (149)
Series A (250)
Series B (189)
Service/supplier (12)
Sickle cell disease (99)
Special edition (20)
Spinal muscular atrophy (157)
Sponsored (45)
Startups (3645)
State (1)
Stomach cancer (14)
Supply chain (95)
Tariffs (75)
The Weekly (64)
Vaccines (1020)
Venture capital (89)
Weight loss (371)
Women's health (88)
Worklife (22)
Date
Today (26)
Last 7 days (584)
Last 30 days (2009)
Last 365 days (29315)
2026 (3443)
2025 (29703)
2024 (33855)
2023 (38222)
2022 (48535)
2021 (53619)
2020 (52662)
2019 (46542)
2018 (35397)
2017 (32129)
2016 (31677)
2015 (37053)
2014 (29843)
2013 (26484)
2012 (28029)
2011 (28277)
2010 (26889)
Location
Africa (961)
Alabama (86)
Alaska (7)
Arizona (260)
Arkansas (14)
Asia (41407)
Australia (7388)
California (10688)
Canada (3142)
China (1091)
Colorado (458)
Connecticut (458)
Delaware (331)
Europe (96728)
Florida (1609)
Georgia (357)
Hawaii (4)
Idaho (59)
Illinois (883)
India (69)
Indiana (519)
Iowa (23)
Japan (426)
Kansas (121)
Kentucky (41)
Louisiana (27)
Maine (74)
Maryland (1305)
Massachusetts (7651)
Michigan (352)
Minnesota (585)
Mississippi (6)
Missouri (139)
Montana (34)
Nebraska (28)
Nevada (117)
New Hampshire (77)
New Jersey (2964)
New Mexico (30)
New York (2913)
North Carolina (1464)
North Dakota (10)
Northern California (5190)
Ohio (325)
Oklahoma (23)
Oregon (43)
Pennsylvania (2094)
Puerto Rico (24)
Rhode Island (46)
South America (1266)
South Carolina (54)
South Dakota (1)
Southern California (4185)
Tennessee (170)
Texas (1681)
United States (38423)
Utah (325)
Vermont (1)
Virginia (259)
Washington D.C. (77)
Washington State (907)
West Virginia (4)
Wisconsin (126)
Wyoming (2)
701,651 Results for "university of applied sciences berlin".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Cancer
ADC, Bispecifics and Kinase Blockers Steal the Spotlight at ESMO 2025 in Berlin
Pfizer, Merck, AstraZeneca and Bristol Myers Squibb were among the many biopharmas showing off novel cancer modalities at ESMO, with antibody-drug conjugates, bispecific antibodies and kinase inhibitors demonstrating encouraging efficacy and safety for various cancers.
October 22, 2025
·
4 min read
·
Tristan Manalac
Press Releases
Cycle Pharmaceuticals Announces Extension of Applied Therapeutics Tender Offer
January 29, 2026
·
7 min read
Press Releases
OKI Establishes OKI Berlin Lab R&D Center in Berlin, Germany
June 2, 2025
·
3 min read
Press Releases
Berlin Heals Holding AG Successfully Completes Enrollment in Phase I of the CMIC-III Less Invasive Study
October 10, 2025
·
3 min read
Press Releases
University of Phoenix appoints Sheila Babendir as Dean of the College of Social and Behavioral Sciences
January 21, 2026
·
3 min read
Press Releases
Cycle Pharmaceuticals Completes Acquisition of Applied Therapeutics
February 4, 2026
·
1 min read
Press Releases
University of Pennsylvania, BioNTech, and OUP Launch $50 Million Life Sciences Fund
January 12, 2026
·
6 min read
Press Releases
TREOS Bio Partners with Charité Berlin and Junshi Biosciences to Launch Pivotal Phase II Clinical Trial in Refractory MSS Colorectal Cancer
August 28, 2025
·
3 min read
Press Releases
Cycle Pharmaceuticals to Acquire Applied Therapeutics
December 12, 2025
·
10 min read
Press Releases
Berlin Heals Holding AG Successfully Raises Over 5Million USD Round for Advancing New Less Invasive Approaches
September 1, 2025
·
2 min read
1 of 70,166
Next
